Hagens Berman Sobol Shapiro LLP, a top-tier investor-rights law firm, advises investors of the Nov. 4, 2014 lead plaintiff deadline in the securities fraud class action against Marrone Bio Innovations, Inc. . Investors who purchased Marrone securities between March 6, 2014 and September 2, 2014 should contact Hagens Berman Partner Reed Kathrein, who is leading the firm's investigation, by calling 725-3000, emailing MBII@hbsslaw.com or visiting http://hb-securities.com/investigations/MBII .
↧